An article published recently in the MLO in the USA adds further evidence to the benefits of using plasma viscosity testing when managing patients suffering from COVID-19. It follows on from the study published by Addenbrookes Hospital in Cambridge earlier this year.
With the growing body of evidence for the use of plasma viscosity testing for managing COVID-19, now is the time to explore how our clinical viscometers can help healthcare professionals to better utilise their resources during the pandemic.
